Improving vascular function in hypertension: potential benefits of combination therapy with amlodipine and renin–angiotensin–aldosterone system blockers
Author:
- 1 January 2010
- journal article
- review article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 28 (1) , 2-8
Abstract
Hypertension is characterized by endothelial dysfunction and increased risk for adverse cardiovascular outcomes. In addition to lowering blood pressure, the calcium-channel blocker amlodipine and blockers of the renin-angiotensin-aldosterone system (angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers) may further reduce cardiovascular risk by improving endothelial function when used alone or in combination. In fact, the beneficial effects of the combination of amlodipine and a renin-angiotensin-aldosterone system blocker on endothelial function have been found to be greater than the effect of either drug alone, likely due to additive effects on nitric oxide activity. This review summarizes the observed effects of these agents on endothelial function and the complementary mechanisms by which they act, thus providing rationale (beyond blood pressure benefits) for their use in combination.Keywords
This publication has 61 references indexed in Scilit:
- Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trialsBMJ, 2008
- Effects of Valsartan or Amlodipine on Endothelial Function and Oxidative Stress after One Year Follow-up in Patients with Essential HypertensionClinical and Experimental Hypertension, 2008
- Differential effects of AT1 receptor and Ca2+ channel blockade on atherosclerosis, inflammatory gene expression, and production of reactive oxygen speciesAtherosclerosis, 2007
- Effect of angiotensin II type 1 receptor antagonism on endothelial function: role of bradykinin and nitric oxideJournal Of Hypertension, 2006
- AT receptors and L-type calcium channels: functional coupling in supersensitivity to angiotensin II in diabetic ratsCardiovascular Research, 2005
- Serum levels of thiobarbituric acid reactive substances predict cardiovascular events in patients with stable coronary artery diseaseJACC, 2004
- Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension, 2003
- Angiotensin AT 2 Receptors Directly Stimulate Renal Nitric Oxide in Bradykinin B 2 -Receptor–Null MiceHypertension, 2003
- Different Effect of Antihypertensive Drugs on Conduit Artery Endothelial FunctionHypertension, 2003
- Effects of Antihypertensive Drugs on Endothelial DysfunctionDrugs, 2002